LOW-VOLUME · FEMALE-LED
oxytocin Side Effects
oxytocin (also sold as Pitocin) is a LOW-VOLUME FAERS extract #432 of 524 by FAERS report count. Still opens on FEMALE-LED: 87% of sex-coded reports are female (2,132 F / 321 M).
Data updated 2026-05-15
- 2,902
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
oxytocin reporting skew - 87% of sex-coded reports are female (2,132 F / 321 M). Volume band LOW-VOLUME #432 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for oxytocin (Pitocin) (2,902 reports #432 of 524 by FAERS report count). 87% of sex-coded reports are female (2,132 F / 321 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (1996–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
FOETAL EXPOSURE DURING PREGNANCY leads 429 of 2,902 reports
FEMALE-LED reporters · age peak 18-44
Female-led reporters (87% of sex-coded rows)
Age peak 18-44 (1,546 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (149 reports, 5.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| FOETAL EXPOSURE DURING PREGNANCY | 34 |
| FOETAL DEATH | 24 |
| DEATH | 22 |
| HYPOTENSION | 16 |
| CARDIAC ARREST | 15 |
| CONDITION AGGRAVATED | 14 |
| DRUG EXPOSURE DURING PREGNANCY | 12 |
| EXPOSURE DURING PREGNANCY | 12 |
| MATERNAL EXPOSURE DURING PREGNANCY | 12 |
| METABOLIC ACIDOSIS | 11 |
| PYREXIA | 11 |
| RESPIRATORY DISTRESS | 11 |
| DYSPNOEA | 10 |
| SMALL FOR DATES BABY | 10 |
| VASCULAR RESISTANCE SYSTEMIC INCREASED | 10 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 9 |
| PULMONARY OEDEMA | 9 |
| SEPTIC SHOCK | 9 |
| CARDIO-RESPIRATORY ARREST | 8 |
Reactions in Hospitalization Reports
Hospitalization mid-share (848, 29.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| MATERNAL EXPOSURE DURING PREGNANCY | 146 |
| FOETAL EXPOSURE DURING PREGNANCY | 111 |
| EXPOSURE DURING PREGNANCY | 90 |
| PREMATURE BABY | 68 |
| PREMATURE DELIVERY | 61 |
| CAESAREAN SECTION | 50 |
| MATERNAL EXPOSURE DURING DELIVERY | 50 |
| DRUG EXPOSURE DURING PREGNANCY | 47 |
| DYSPNOEA | 40 |
| HYPOTENSION | 40 |
| PAIN | 38 |
| POSTPARTUM HAEMORRHAGE | 38 |
| NAUSEA | 34 |
| TACHYCARDIA | 34 |
| VOMITING | 33 |
| HYPERTENSION | 32 |
| HAEMOGLOBIN DECREASED | 27 |
| PYREXIA | 27 |
How to read oxytocin FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-MID)
FAERS holds 2,902 voluntary reports linked to oxytocin (Pitocin), 1996-2025. Death is listed on 149 (5.1%). Hospitalization appears on 848 (29.2%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and FEMALE-LED skew still differ by drug; not a complete safety profile.
Read with oxytocin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 2,896 FAERS cases (Δ 6 lighter vs oxytocin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 2,870 FAERS cases (Δ 32 lighter vs oxytocin); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 2,935 FAERS cases (Δ 33 heavier vs oxytocin); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 2,938 FAERS cases (Δ 36 heavier vs oxytocin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 57.0 pp vs oxytocin's DEATH-HEAVY): CASELOAD · HOSP-MID.
oxytocin stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.